Aposense
Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Aposense Information
Geographic Data
Address:
City: Petah Tiqva
State: HaMerkaz
Zip:
Country: Israel
Financial Info
Stage:
series unknown
Raised Last:
$3M
Raised Total:$22M
Social
Metrics
9,524,656Website Global Rank
141Website Monthly Traffic
Twitter Followers
Description
Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple disease categories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy. Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core. Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2006 | Venture Round | 1 | $12M |
Ziegler Meditech Equity Partners Ziegler Meditech Equity Partners |
8/2008 | Venture Round | 9 | $7.3M |
Bargal R&a;D Investment Clal Biotechnology Industries Docor International Management Federman &a; Sons Phoenix Insurance Polar Investments Pontifax Technorov Holdings Ziegler Meditech Equity Partners Bargal R&a;D Investment Clal Biotechnology Industries Docor International Management Federman &a; Sons Phoenix Insurance Polar Investments Pontifax Technorov Holdings Ziegler Meditech Equity Partners |
5/2010 | Venture Round | 2 | $3M |
Pontifax Ziegler Meditech Equity Partners Pontifax Ziegler Meditech Equity Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
